ARMA and GERDx
ARMA is a relatively new procedure developed to treat gastroesophageal reflux disease.
ARMA (anti-reflux Mucosal Ablation) comprises ablation of the subcardial mucosa to stimulate scar retraction which closes the cardiac incompetence. In ARMA, the gastric tissue is destroyed and not removed.
Why and when is it done
Gastroesophageal reflux disease (GERD) is a common disorder with an increasing prevalence. Proton pump inhibitors (PPIs) are effective in achieving symptom control and preventing complications. Approximately 40 % of patients have persistent GERD symptoms despite PPI therapy, and there is increasing awareness with regard to the side effects of life-long PPI use
ARMA, a new endoscopic treatment for PPI-refractory GERD, is simple, safe, and improves GERD-related symptoms and objective acid reflux parameters.
How is the procedure performed
In patients fulfilling inclusion criteria and willing for ARMA, the procedure involves ablation of the mucosa of the EGJ using TT knife (ARMA).
Subsequently, saline solution mixed with indigo-carmine is injected at the submucosa level to raise a submucosal bleb, followed by ablation of the mucosa along the lesser curvature using TT knife.
